Last edition
News about
Lilly’s acquisition of Orna Therapeutics aims to accelerate development of in vivo CAR-T therapies powered by engineered circular RNA and advanced lipid nanoparticle delivery platforms.
This collaboration with Frontier Space provides an opportunity for Azenta to demonstrate how its sample management technologies perform in demanding research environments, helping extend use of its high-precision consumables into new research settings and next-generation workflows, further reinforcing the company's leadership in sample integrity.
IPC Signs Three MoUs to Strengthen Medicine Safety and Quality Standards
The Indian Pharmacopoeia Commission (IPC)has signed three MoUs to strengthen medicine safety and quality, including partnerships with the Goa State Pharmacy Council (GSPC)and the Quality Council of India (QCI) to boost pharmacovigilance, training and healthcare quality initiatives.
Abbott has reported positive late-breaking data from the VERITAS Study showing its Amulet 360 Left Atrial Appendage Occluder met safety and effectiveness endpoints, supporting its potential to reduce stroke risk in patients with non-valvular atrial fibrillation.
FUJIFILM Biotechnologies Enhances UK Manufacturing with Advanced Downstream Purification System
FUJIFILM Biotechnologies has announced plans to deploy its proprietary downstream purification system at its manufacturing facility in the United Kingdom, aiming to enhance production efficiency and expand biopharmaceutical processing capabilities.
India Begins First Human Trials of Indigenous KFD Vaccine
The Indian Council of Medical Research (ICMR), in partnership with Indian Immunologicals, has advanced an indigenous vaccine candidate for Kyasanur Forest Disease (KFD), commonly known as monkey fever, into Phase I human clinical trials.
FDA Issues 11 Observations to Aurobindo Pharma Manufacturing Facility
Aurobindo Pharma has reported that its formulation manufacturing facility in Telangana received 11 procedural observations from the United States Food and Drug Administration (FDA) after a routine inspection.
Delonix Bioworks Secures NMPA IND Clearance for MenB Vaccine Candidate DX-104
China grants IND approval for DX-104 after Australia CTN clearance, paving the way for Phase I trials of Delonix’s engineered Group B meningococcal vaccine.
Genesys Spine Reports Positive Multicentre Study Results for SIros SI Joint Fusion System
Prospective multicentre data show significant pain reduction, improved function and strong fusion outcomes with the SIros Lateral Sacroiliac Joint Fusion System.
Novartis Builds Global Biomedical Research Centre in San Diego
Novartis launches construction of a 466,000-square-foot biomedical research centre in San Diego, set to open in 2029, strengthening global drug discovery and advancing neuroscience, oncology and next-generation therapies.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy